Pensionfund Sabic Biogen Inc. Transaction History

Pensionfund Sabic

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$282.99 - $369.05 $2.38 Million - $3.1 Million	-8,400 Closed	0 $0
Q2 2021 Jul 01, 2021	BUY	$259.0 - $414.71 $103,600 - $165,884	400 Added 5.0%	8,400 $2.91 Million
Q1 2021 Apr 01, 2021	SELL	$242.95 - $284.63 $121,475 - $142,315	-500 Reduced 5.88%	8,000 $2.24 Million
Q3 2020 Oct 05, 2020	BUY	$264.77 - $305.71 $264,770 - $305,710	1,000 Added 13.33%	8,500 $2.41 Million
Q2 2019 Jul 02, 2019	BUY	$219.29 - $241.72 $307,006 - $338,408	1,400 Added 22.95%	7,500 $1.75 Million
Q1 2019 Apr 01, 2019	SELL	$216.71 - $338.96 $216,710 - $338,960	-1,000 Reduced 14.08%	6,100 $1.44 Million
Q3 2018 Oct 01, 2018	SELL	$293.51 - $383.83 $293,510 - $383,830	-1,000 Reduced 12.35%	7,100 $2.51 Million
Q1 2018 Apr 03, 2018	BUY	$260.13 - $367.91 $104,052 - $147,164	400 Added 5.19%	8,100 $2.22 Million
Q3 2017 Oct 04, 2017	BUY	$281.15 - $329.69 $2.16 Million - $2.54 Million	7,700	7,700 $2.41 Million

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pensionfund Sabic, based on Form 13F filings with the SEC.

Stay updated on Pensionfund Sabic with notifications on news.